The Discounted Cash Flow (DCF) valuation of Globus Medical Inc (GMED) is 35.26 USD. With the latest stock price at 56.22 USD, the upside of Globus Medical Inc based on DCF is -37.3%.
Based on the latest price of 56.22 USD and our DCF valuation, Globus Medical Inc (GMED) is a sell. selling GMED stocks now will result in a potential gain of 37.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.9% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 22.02 - 90.60 | 35.26 |
| Upside | -60.8% - 61.2% | -37.3% |